Vernonia cinerea regenerates tubular epithelial cells in cisplatin induced nephrotoxicity in cancer bearing mice without affecting antitumor activity

10.1016/j.jtcme.2020.08.004

Arul Amuthan；Vasudha Devi；Chandrashekara Shastry Shreedhara；Venkata Rao；Shiny Jasphin；Nitesh Kumar

Vernonia cinerea ； Astaxanthin ； Ayurveda ； Siddha ； Betulin ； Cisplatin ； Nephrotoxicity ； Nephroprotection

Journal of Traditional and Complementary Medicine

11卷3期（2021 / 05 / 01）

279 - 286

英文

Background: Traditional Siddha Medicine advises using metal-based formulations to treat cancers. In the case of any toxicities during the therapy, Siddha physicians use Vernonia cinerea (VC) whole plant kashayam (crude aqueous extract-CAE) to reverse the toxic effects. Aim: To evaluate the nephroprotective activity of CAE and its fractions in cisplatin-induced nephrotoxicity and to assess whether they compromise the anticancer efficacy of cisplatin. Materials and methods: Cisplatin-induced renal damage was induced in Ehrlich Ascites Carcinoma (EAC) bearing mice during mild phase of tumor growth. CAE and its butanol (BF) and aqueous (AF) fractions were administered orally from the 5th day for five days. Nephroprotective potential (serum urea, creatinine, renal histology) and effect of VC on cisplatin anticancer efficacy (tumor volume, viable tumor cells, percentage increase in life span (% ILS)) were calculated. Result: CAE and its fractions significantly reversed the cisplatin-induced renal damage. CAE and BF treated animals showed regeneration of 50%-75% of proximal tubular cells. Compared to EAC control mice, the % ILS of the cisplatin-treated group was 244% and it was further extended to 379% after CAE administration. The % ILS in the CAE treated group was 1.6 times higher than the cisplatin alone treated group. GC-MS study showed the presence of astaxanthin and betulin. Conclusion: CAE of VC reverses cisplatin-induced kidney damage as well as regenerates proximal tubular epithelial cells, without compromising the anticancer effect of cisplatin. When CAE was further fractionated, the nephroprotective activity was retained, but the beneficial anticancer effect of cisplatin was compromised.

1. Common cancer sites - cancer stat facts. https://seer.cancer.gov/statfacts/html/common.html. Accessed June 20, 2019.
2. Global status report on noncommunicable diseases. http://www.sicasalud.net/sites/default/files/Global NCD Report 2011.pdf; 2010. Accessed June 20, 2019.
3. Amuthan, A,Devi, V,Shreedhara, CS,Rao, V,Puri, K,Jasphin, S(2019).Vernonia cinerea (neichitti keerai) regenerates proximal tubules in cisplatininduced renal damage in mice.Asian J Pharmaceut Clin Res,12(1),332-335.
4. Bhande, RM,Kalyani, P,Setty, SR,Ramesh, H,Sreenvasa, K(2010).Pharmacognostical evaluation of leaves of Vernonia cinerea less.Biomed Pharmacol J,3(1),87-91.
5. Cai, X,Chen, Y,Xie, X,Yao, D,Ding, C,Chen, M(2019).Astaxanthin prevents against lipopolysaccharide-induced acute lung injury and sepsis via inhibiting activation of MAPK/NF-kappaB.Am J Transl Res,11(3),1884-1894.
6. Chief, Editor(1999).Government of India notifies the rules for breeding of and conducting animal experiments.Indian J Pharmacol,31(1),92-95.
7. Dagawal, M,Tarekar, D(2017).Pharmacognostic studies of Vernonia cinerea (L.) Leaves- an antismoking plant.World J Pharmaceut Res,6(1),875-882.
8. Dinnimath, BM,Jalalpure, SS,Patil, UK(2017).Antiurolithiatic activity of natural constituents isolated from Aerva lanata.J Ayurveda Integr Med,8(4),226-232.
9. Dobyan, DC,Levi, J,Jacobs, C,Kosek, J,Weiner, MW(1980).Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations.J Pharmacol Exp Therapeut,213(3),551-556.
10. Harborne, JB(1998).Method of Extraction and Isolation in Phytochemical Methods.London:Chapman and Hall.
11. Hirama, M,Isonishi, S,Yasuda, M,Ishikawa, H(2006).Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells.Oncol Rep,16(5),997-1002.
12. Jiang, M,Wei, Q,Wang, J(2006).Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.Oncogene,25(29),4056-4066.
13. Kruidering, M,Van de Water, B,de Heer, E,Mulder, GJ,Nagelkerke, JF(1997).Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain.J Pharmacol Exp Therapeut,280(2),638-649.
14. Kuo, Y-H,Kuo, Y-J,Yu, A-S(2003).Two novel sesquiterpene lactones, cytotoxic vernolide-A and -B, from Vernonia cinerea.Chem Pharm Bull,51(4),425-426.
15. Latcha, S,Jaimes, EA,Patil, S,Glezerman, IG,Mehta, S,Flombaum, CD(2016).Article longterm renal outcomes after cisplatin treatment.Clin J Am Soc Nephrol,11,1173-1179.
16. Lee, S,Kim, W,Moon, S-O(2006).Rosiglitazone ameliorates cisplatin-induced renal injury in mice.Nephrol Dial Transplant,21(8),2096-2105.
17. Leelarungrayub, D,Pratanaphon, S,Pothongsunun, P,Sriboonreung, T,Yankai, A,Bloomer, RJ(2010).Vernonia cinerea Less. supplementation and strenuous exercise reduce smoking rate: relation to oxidative stress status and beta-endorphin release in active smokers.J Int Soc Sports Nutr,7,21.
18. Noori, S,Mahboob, T(2002).Effectiveness of carnosine on disturbed electrolytes homeostasis induced by cisplatin.Afr J Biotechnol,10(37),728-e7293.
19. Olivero, OA,Chang, PK,Lopez-Larraza, DM,Semino-Mora, MC,Poirier, MC(1997).Preferential formation and decreased removal of cisplatin-DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA.Mutat Res,391(1-2),79-86.
20. Pai, KSR,Srilatha, P,Suryakant, K(2012).Anticancer activity of Berberis aristata in Ehrlich ascites carcinoma-bearing mice: a preliminary study.Pharm Biol,50(3),270-277.
21. Pillai, CK(2006).Siddha Materia Medica- Vegetable Kingdom. Vol-1.Chennai, India:Rathna Nayakar & Sons.
22. Prasad, S,Rosangkima, G,Khynriam, D(2006).Cisplatin-induced toxicological effects in relation to the endogenous tissue glutathione level in tumor-bearing mice.Asian J Exp Sci.,20,55-68.
23. Puttarak, P,Pornpanyanukul, P,Meetam, T,Bunditanukul, K,Chaiyakunapruk, N(2018).Efficacy and safety of Vernonia cinerea (L.) Less. for smoking cessation: a systematic review and meta-analysis of randomized controlled trials.Compl Ther Med,37,37-42.
24. Qian, W,Nishikawa, M,Haque, AM(2005).Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death.Am J Physiol Cell Physiol,289(6),C1466-C1475.
25. Ramesh, G,Reeves, WB(2005).p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice.Am J Physiol Ren Physiol,289(1),F166-F174.
26. Ramesh, G,Reeves, WB(2003).TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure.Am J Physiol Ren Physiol,285(4),F610-F618.
27. Ramesh, G,W, RB(2004).Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-α.Kidney Int,65(2),490-498.
28. Sakurai, H(2010).Overview and frontier for the development of metal-lopharmaceutics.J Health Sci.,56(2),129-143.
29. Santoso, JT,Lucci, JA, 3rd,Coleman, RL,Schafer, I,Hannigan, EV(2003).Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.Canc Chemother Pharmacol,52(1),13-18.
30. Taguchi, T,Nazneen, A,Abid, MR,Razzaque, MS(2005).Cisplatin-associated nephron-toxicity and pathological events.Contrib Nephrol,148,107-121.
31. Yao, X,Panichpisal, K,Kurtzman, N,Nugent, K(2007).Cisplatin nephrotoxicity: a review.Am J Med Sci.,334(2),115-124.
32. Zhao, H,Zheng, Q,Hu, X,Shen, H,Li, F(2016).Betulin attenuates kidney injury in septic rats through inhibiting TLR4/NF-kappaB signaling pathway.Life Sci.,144,185-193.